📑SANDOSTATIN LAR 20 MG., LOCION LINDANO 1%, LOCION PERMETRINAS 5%.
Procurement process summary
This process is to purchase Sandostatin lar 20 mg., locion lindano 1%, locion permetrinas 5%.
This contract was awarded by 🇺🇾 Dirección Nacional de Sanidad Policial for an amount of UYU 33,600 to 1 supplier. It was published on 2003-08-14 through direct
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇺🇾 Dirección Nacional de Sanidad Policial Buying unitnot reported Publication date2003-08-14 Contest statusnot reported DescriptionCompra por Excepción 99/2003Awards
This award was granted to LABORATORIOS CLAUSEN S.A. by Dirección Nacional de Sanidad Policial for an amount of UYU 33,600. The procurement process was conducted through direct for the category of Not available. The award was granted on 2003-08-14.
| Supplier | Amount | Award date |
|---|---|---|
| 🇺🇾 LABORATORIOS CLAUSEN S.A. | UYU 33,600 | 2003-08-14 |
Market context and opportunities
The execution of this contract allows the entity Dirección Nacional de Sanidad Policial to fulfill its public service objectives efficiently.
The direct purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberUY_ocds-yfs5dr-a29949-R-211204600012Publication date2003-08-14Contract datenot reportedAward date2003-08-14Categoriesnot reportedPurchase modalitydirectMethod detailsCompra por ExcepciónStatusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
